Moreover, data from cBioPortal database (https://www.cbioportal.org/) reveals that TOPK mutations, included missense, fusion, and insertions, are present in cancers such as renal non-clear cell carcinoma, ovarian epithelial tumor, and glioblastoma (Supplement Figure 1A-B) 29-31. This evidence concerns the gene PBK and cancer.